Filing Details
- Accession Number:
- 0001209191-15-071650
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-21 16:13:18
- Reporting Period:
- 2015-09-17
- Filing Date:
- 2015-09-21
- Accepted Time:
- 2015-09-21 16:13:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1177082 | Daniel Lynch | C/O Bluebird Bio, Inc. 150 Second Street Cambridge MA 02141 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-09-17 | 1,500 | $2.09 | 1,500 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-09-17 | 1,500 | $140.06 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2015-09-17 | 1,500 | $0.00 | 1,500 | $2.09 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
27,508 | 2021-07-13 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 25, 2015.
- The range of prices for the transaction reported on this line was $140.00 to $140.41. The average weighted price was $140.0587. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This option vests over a four-year period in 48 equal monthly installments beginning on April 15, 2011